Advances in Molecular Function and Recombinant Expression of Human Collagen
- PMID: 40143206
- PMCID: PMC11945623
- DOI: 10.3390/ph18030430
Advances in Molecular Function and Recombinant Expression of Human Collagen
Abstract
Collagen is the main protein found in skin, bone, cartilage, ligaments, tendons and connective tissue, and it can exhibit properties ranging from compliant to rigid or form gradients between these states. The collagen family comprises 28 members, each containing at least one triple-helical domain. These proteins play critical roles in maintaining mechanical characteristics, tissue organization, and structural integrity. Collagens regulate cellular processes such as proliferation, migration, and differentiation through interactions with cell surface receptors. Fibrillar collagens, the most abundant extracellular matrix (ECM) proteins, provide organs and tissues with structural stability and connectivity. In the mammalian myocardial interstitium, types I and III collagens are predominant: collagen I is found in organs, tendons, and bones; collagen II is found in cartilage; collagen III is found in reticular fibers; collagen IV is found in basement membranes; and collagen V is found in nails and hair. Recombinant human collagens, particularly in sponge-like porous formats combined with bone morphogenetic proteins, serve as effective scaffolds for bone repair. Due to their biocompatibility and low immunogenicity, collagens are pivotal in tissue engineering applications for skin, bone, and wound regeneration. Recombinant technology enables the production of triple-helical collagens with amino acid sequences identical to human tissue-derived collagens. This review summarizes recent advances in the molecular functions and recombinant expression of human collagens, with a focus on their biomedical applications.
Keywords: biological properties; collagen structure; extracellular matrix; molecular function; recombinant collagen.
Conflict of interest statement
Kun Ma and Shubin Wang are employed by Hantide Biomedical Group Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
Figures
Similar articles
-
The application of recombinant human collagen in tissue engineering.BioDrugs. 2004;18(2):103-19. doi: 10.2165/00063030-200418020-00004. BioDrugs. 2004. PMID: 15046526 Review.
-
Basic Structure, Physiology, and Biochemistry of Connective Tissues and Extracellular Matrix Collagens.Adv Exp Med Biol. 2021;1348:5-43. doi: 10.1007/978-3-030-80614-9_2. Adv Exp Med Biol. 2021. PMID: 34807414
-
Basic Components of Connective Tissues and Extracellular Matrix: Fibronectin, Fibrinogen, Laminin, Elastin, Fibrillins, Fibulins, Matrilins, Tenascins and Thrombospondins.Adv Exp Med Biol. 2021;1348:105-126. doi: 10.1007/978-3-030-80614-9_4. Adv Exp Med Biol. 2021. PMID: 34807416
-
Genetic heterogeneity of collagens.J Invest Dermatol. 1982 Jul;79 Suppl 1:25s-30s. J Invest Dermatol. 1982. PMID: 7086189
-
Enigmatic insight into collagen.J Oral Maxillofac Pathol. 2016 May-Aug;20(2):276-83. doi: 10.4103/0973-029X.185932. J Oral Maxillofac Pathol. 2016. PMID: 27601823 Free PMC article. Review.
Cited by
-
Proteomic Study Between Interstitial Channels Along Meridians and Adjacent Areas in Mini-Pigs.Biomolecules. 2025 Jun 1;15(6):804. doi: 10.3390/biom15060804. Biomolecules. 2025. PMID: 40563444 Free PMC article.
References
-
- Galdyszynska M., Zwolinski R., Piera L., Szymanski J., Jaszewski R., Drobnik J. Stiff substrates inhibit collagen accumulation via integrin α2β1, FAK, Src kinases in human atrial fibroblast and myofibroblast cultures derived from patients with aortal stenosis. Biomed. Pharmacother. 2023;159:114289. doi: 10.1016/j.biopha.2023.114289. - DOI - PubMed
-
- Gronlien K.G., Pedersen M.E., Ronning S.B., Solberg N.T., Tonnesen H.H. Tuning of 2D cultured human fibroblast behavior using lumichrome photocrosslinked collagen hydrogels. Mat. Today Commun. 2022;31:103635. doi: 10.1016/j.mtcomm.2022.103635. - DOI
-
- Shahrajabian M.H., Sun W., Cheng Q. Traditional herbal medicine for the prevention and treatment of cold and flu in the autumn of 2020, overlapped with COVID-19. Nat. Prod. Commun. 2020;15:1–20. doi: 10.1177/1934578X20951431. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources